Katiane Tostes

7PUBLICATIONS
36CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 06, 2026
Dendritic cell-based immunotherapy modulates the systemic inflammatory profile in a 4T1 breast cancer model.

|Jul 25, 2026
A baseline systemic inflammatory signature predicts anti-PD-1 response in advanced melanoma.

|Oct 24, 2025
Monocyte-Platelet-Hemoglobin-Hematocrit score and the role of hematological parameters in predicting treatment response to immune checkpoint inhibitors and survival outcomes in non-small cell lung cancer patients-a retrospective study.

Katiane Tostes, Tauana Christina Dias, Gabriela Karam Rebolho

|May 03, 2025
CD24, NFIL3, FN1, and KLRK1 signature predicts melanoma immunotherapy response and survival.

Bruna Pereira Sorroche, Renan de Jesus Teixeira, Vinicius Gonçalves de Souza

|Dec 14, 2023
Unveiling the role of MGMT and DAPK hypermethylation in response to anti-EGFR agents: Molecular insights for advancing HNSCC treatment.

Lidia Maria Rebolho Batista Arantes, Renato José Silva-Oliveira, Ana Carolina de Carvalho

|Aug 12, 2023
Biomarkers for Immune Checkpoint Inhibitor Response in NSCLC: Current Developments and Applicability.

Katiane Tostes, Aléxia Polo Siqueira, Rui Manuel Reis

Pageof 2

Frequent Collaborators

6 joint publications

Lidia Maria Rebolho Batista Arantes

3 joint publications

Bruna Pereira Sorroche

3 joint publications

Renan de Jesus Teixeira

2 joint publications

Gabriela Karam Rebolho